Aival

Aival is a verifiable B2B healthcare startup (aival.io) with a high-utility mission to validate medical AI. External search confirms seed funding (~$1.5M+) and partnerships (e.g., Blackford Analysis). However, the project submission itself contains severely inaccurate data—claiming 'everyone' as the audience and 'most people' as users, while inflating team size (claimed 30 vs. actual ~4-8). These false claims necessitate heavy penalties on Reach and Traction quality factors, resulting in a low score despite the legitimate business model.